Founded in 1998.
Still holding the question of pain relief without side effects, AWG ORIGIN® continues its tuning today.
Through integrated technology and information across health, beauty, and medicine,
our purpose is to support everyone who hopes to live a bright life into the future —
conveying what is truly needed, contributing to society, and running our business with integrity.
Today, many people in Japan live with chronic conditions such as cancer, high blood pressure, and diabetes. Once called “diseases of old age,” they became known over time as “adult diseases,” and now, as they appear at younger ages, they have been renamed “modern diseases” or “lifestyle diseases.”
But “modern disease” carries another, harsher definition: an illness that the symptomatic treatment of modern medicine (drugs) alone cannot cure at the root. At the heart of that maze, we pose one question: “Rather than suppressing cells with drugs, could we help them regain their original resonance?” Through an approach that draws on cutting-edge quantum medicine and biological frequencies (QPA), ASIAS works to “tune” the network of life and help guide people toward the exit from the maze.
Much of medical practice today centers on “symptomatic treatment” that eases pain and distress. These are, of course, indispensable — a temporary support for getting through hard symptoms.
However, “symptom-suppressing drugs” that lower a fever, lower blood pressure, or take away pain do not remove the root cause of the trouble. In some cases they can even switch off the body’s own natural healing power.
The true “causal therapy” that ASIAS proposes is not about forcing control from the outside with drugs. It is about using specific frequencies (QPA) to unravel the disturbance of information that has arisen in the network between cells (the fascia), and to awaken the body’s inherent capacity to heal on its own. We call this “tuning.”
The AWG ORIGIN® / QPA™ wave-therapy device is designed to resonate with and amplify the causes of pain in the body at a quantum level and work to remove them. ASIAS shares the importance of addressing the pain at the root of illness while also restoring the immune and healing power inherent in the human body, and keeps thinking about what “health” means.
From April of that year, began work as a veterinarian at Tochigi Dairy.
Established as a research base for artificial-insemination technology in cattle. The search for frequencies that protect sperm from viruses and bacteria became the starting point for the later development of AWG ORIGIN® / QPA®.
Within veterinary medicine, began research into “a frequency at which sperm survive but E. coli die.” This became the fundamental question that later developed into AWG (Arbitrary Waveform Generator).
Advanced joint research on frozen semen and embryo transfer in cattle and pigs. Also provided technical guidance and conducted experiments in South Korea and Taiwan, building an international research foundation.
Became President and Representative Director. Expanded the business by setting up artificial-insemination centers across Japan, in South Korea, and elsewhere. Succeeded with frozen-sperm artificial-insemination technology and was recognized as a pioneer in the field.
Entrusted management to the next generation and devoted himself to product development and to the research and business activities aimed at expanding overseas. He poured his energy into spreading AWG ORIGIN technology until his final years.
The INTERNATIONAL ROYAL ACADEMY OF THE UNITED NATIONS (IRAUN) selected and honored him as an Honored Doctor of Medicine in recognition of his substantial contributions to medicine, education, and culture. He was also recognized as an honorary member of the Royal Heritage Academy.
At the age of 86. His will lives on in the AWG ORIGIN® / QPA® technology and in the work of the Matrix Integrative Medicine Research Association (MIMRA).
Carrying frozen-semen and embryo-transfer technology, Masayuki Matsuura traveled the livestock sites of South Korea and Taiwan and built a foundation of trust on the ground. Just as momentum was building — a sense that “the real work starts now” — a collaborator died suddenly amid political upheaval, followed by the death of the factory manager who had helped support product development in Japan. The two losses shook the foundations of the business, but Matsuura did not stop. He continued his research even as he lost his sight, and passed the core of the technology to the next generation — from “Dr. Hi-Ezex” to “AWG ORIGIN®.” With legal compliance as its foundation, ASIAS Corp. will honestly carry the question its developer kept asking, for the good of society and its people.
Introduced as “Dr. Hi-Ezex.” Drew attention as a form of advanced medicine that physically destroys viruses and bacteria.
Renamed from “Dr. Hiexex.” Began selling the “AC series” of low-frequency therapy devices.
Commissioned research using AWG ORIGIN® / QPA®.
At Aichi Medical University
“A consideration of the lifestyle-disease-prevention effects of a low-frequency therapy device” (Chiba Med. J. 100E: 39–48, 2024)
“How AWG ORIGIN® works to balance the dynamic equilibrium of the fascia”
| Date | Item | Author / outlet |
|---|---|---|
| 2004/09 | Cancer Can Be Cured with Abo’s Immunology and Ueno-Style Alternative Medicine (in Japanese) | Toru Abo & Hiroiku Ueno |
| 2008 | [Society journal] Ayurveda Research No. 38, 39 | Kazui Hoshi |
| 2009/03 | [Society journal] Overcoming Cancer with Integrative Medicine vol. 9 | Japanese oncology society (ed.) |
| 2011/12 | “AWG”: Magic or Medicine? (revised ed., in Japanese) | Masaki Toshinari |
| 2013/12 | [Society journal] Journal of the Psi Society vol. 35 — The World of Dark-Field Microscopy | Taiji Ujihashi |
| 2014/01 | Wake Up! The Patient Revolution (in Japanese) | Katsunari Nishihara |
| 2014/09 | Progress in Cancer Immunotherapy Will Save Japan (in Japanese) | Kihachiro Takahara |
| 2017/03 | The Secret Frequency at Which Somatids Burst with Joy (in Japanese) | Taiji Ujihashi |
| 2018/10 | [Medical paper, J-GLOBAL] Cancer pain treatment using an AWG treatment device | Toru Fujita |
| 2019/03 | Why Does Treatment for Intractable Diseases Fail? (in Japanese) | Toru Fujita |
| 2020/12 | The Birth of Quantum Medicine (in Japanese) — first use of the name “QPA” | Kunio Yasue & Masanori Kobayashi |
| 2023/01 | The Magic Frequency: AWG ORIGIN® (in Japanese) | Hikaruland editorial team |
| 2024/09 | [Peer-reviewed paper] Chiba Med. J. 100E: 39–48 | Chiba University |
| 2025/12 | Why Does Pain Disappear When the “Fascia” Resonates?! (in Japanese) | Hiroto Koike |
ASIAS Corp. is the company that officially provides information on AWG ORIGIN® / QPA® — related books, technical explanations, and information about the facilities that use it. Beyond product information, our official site also organizes and publishes related books, technical explanations, facility introductions, and company information.
| Company name | ASIAS Corp. Kabushiki Kaisha ASIAS |
|---|---|
| Founded | 1998 |
| Address | Hamakita Chuo Bldg. 301 150-1 Numa, Hamana-ku, Hamamatsu-shi Shizuoka 434-0037, Japan |
| TEL | +81-53-424-8888 |
| Contact | Inquiry form (English inquiries welcome) |
| Capital | JPY 20 million |
| Representative Director | Yasuhiro Nagata |
| Business hours | 9:00–17:00 (JST) (Closed Saturdays, Sundays, public holidays, and during summer and year-end periods) |
| License | License for the sale and lease of highly controlled medical devices Hamaken Hama-A No. 11-820
Click to enlarge
|
Feel free to reach out about introduction consultations, product questions, press enquiries, or academic collaboration.
We publish, to the extent it can be made public, the representative’s background, related qualifications, awards, and course-completion certificates. These are reference materials for understanding how ASIAS came to do this work and the background to its information activities on AWG ORIGIN® / QPA®.
The materials below are an organized set of certificates, awards, and course-completion certificates that can be made public. Each is provided as a reference for confirming the background of ASIAS’s work and the representative’s career.